Viewing Study NCT06640166

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2026-02-02 @ 6:48 AM
Study NCT ID: NCT06640166
Status: RECRUITING
Last Update Posted: 2025-02-12
First Post: 2024-10-07
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Carcinoma View
None Colorectal Neoplasms View
None Colorectal Tumor View
None Colorectal Adenocarcinoma View
None Colorectal Cancer (CRC) View
None Colorectal Cancer View
None Colon Cancer View
None Colon Adenocarcinoma View
None Colon Carcinoma View
None Colon Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BRAF View
None V600E View
None encorafenib View
None cetuximab View
None colorectal cancer View
None FOLFIRI View
None BRAF V600E View